No Matches Found
No Matches Found
No Matches Found
Sicagen India Ltd
Sicagen India Ltd is Rated Sell by MarketsMOJO
Sicagen India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Sicagen India Ltd is Rated Sell
Sicagen India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Broad-Based Technical Strength Lifts Sicagen India Ltd to 52-Week High of Rs 58.5
With every major technical indicator signalling momentum, Sicagen India Ltd surged to a fresh 52-week high of Rs 58.5 on 29 May 2026, defying the broader market's downward trend and marking a notable milestone for the micro-cap trading and distribution company.
Sicagen India Ltd is Rated Sell
Sicagen India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 May 2026, providing investors with the most recent insights into the company’s performance and outlook.
Are Sicagen India Ltd latest results good or bad?
Sicagen India Ltd's latest Q4 FY26 results show strong revenue growth at ₹277.91 crores, up 10.49% year-on-year, but net profit declined to ₹4.46 crores, raising concerns due to increased interest expenses and margin compression. Overall, the results are mixed, indicating potential operational sustainability issues.
Sicagen India Q4 FY26: Profit Growth Masks Margin Pressures and Rising Interest Burden
Sicagen India Ltd., a Chennai-based trading and distribution company operating across building materials, power systems, and commercial vehicle dealerships, reported a net profit of ₹4.46 crores for Q4 FY26, marking a year-on-year growth of 12.34% from ₹3.97 crores in Q4 FY25. However, the quarter-on-quarter performance revealed a decline of 9.53% from ₹4.93 crores in Q3 FY26, raising concerns about sustainability of profitability despite robust top-line expansion. The stock has declined 20.52% over the past year, significantly underperforming the Sensex which fell 8.36%, reflecting investor scepticism about the company's ability to translate revenue growth into consistent bottom-line performance.
When is the next results date for Sicagen India Ltd?
The next results date for Sicagen India Ltd is 13 May 2026.
Sicagen India Ltd is Rated Hold by MarketsMOJO
Sicagen India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Sicagen India Ltd Falls to 52-Week Low Amid Mixed Financial Signals
A recent decline has dragged Sicagen India Ltd to its lowest price in 52 weeks, reflecting a complex interplay of valuation, financial performance, and market sentiment despite some encouraging quarterly results.
Broad-Based Technical Strength Lifts Sicagen India Ltd to 52-Week High of Rs 56.8
With a decisive intraday surge to Rs 56.8 on 29 Apr 2026, Sicagen India Ltd has reached a fresh 52-week high, propelled by a confluence of positive technical signals and sustained price momentum despite a modestly negative one-year return.
Sicagen India Ltd is Rated Hold by MarketsMOJO
Sicagen India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Sicagen India Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials
Sicagen India Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Sell to Hold as of 15 Apr 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and recent financial performance, despite ongoing challenges in debt servicing and long-term growth. The stock’s recent price surge of 5.96% and a Mojo Score of 51.0 underpin this reassessment, signalling cautious optimism among investors.
Sicagen India Ltd is Rated Sell by MarketsMOJO
Sicagen India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Sicagen India Ltd Falls to 52-Week Low of Rs 43.64 as Sell-Off Deepens
A sharp decline over the past two sessions has dragged Sicagen India Ltd to a fresh 52-week low of Rs 43.64 on 30 Mar 2026, marking a significant 45% drop from its peak of Rs 79.40 within the last year. This downturn comes amid broader market weakness, but the stock’s underperformance is notably more severe than the benchmark indices.
Sicagen India Ltd Falls to 52-Week Low of Rs 45.35 as Sell-Off Deepens
A sharp decline in Sicagen India Ltd shares has pushed the stock to a fresh 52-week low of Rs 45.35 on 27 Mar 2026, marking a significant 25.89% drop over the past year and underperforming the broader Sensex by over 21 percentage points.
Sicagen India Ltd is Rated Sell by MarketsMOJO
Sicagen India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Sicagen India Ltd Falls to 52-Week Low of Rs 46.5 as Sell-Off Deepens
For the fifth consecutive session, Sicagen India Ltd closed lower, breaching its 52-week low at Rs 46.5 on 23 Mar 2026. This marks a 41.5% decline from its 52-week high of Rs 79.4, underscoring a sustained sell-off amid broader market weakness.
Sicagen India Ltd is Rated Sell
Sicagen India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Sicagen India Ltd Gains 3.11%: 2 Key Factors Driving the Weekly Move
Sicagen India Ltd closed the week ending 6 March 2026 with a gain of 3.11%, outperforming the Sensex which declined 3.00% over the same period. The stock experienced significant volatility, hitting a 52-week low midweek before rebounding sharply on the final trading day. Key developments including a fresh 52-week low and a subsequent downgrade to a Sell rating shaped the week’s price action and investor sentiment.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
